MDR class IIa approved

CE (0344) certified

ISO 13485 certified

MDR class IIa approved

Certified for Europe

TGA approved

ISO 13485 certified

MHRA approved

ISO 27001  certified

Business & integration partners

Research & innovation partners

Next level eye care diagnostics

With global costs of vision loss estimated to be nearly $3 trillion and up to 80% cases of retinal diseases causing visual impairment or blindness that can often be prevented if detected timely, artificial intelligence opens up a whole new possibilities in eye care. Imaging is non-invasive and reliable screening method but requires expertise to analyse/read the acquired images. Using artificial intelligence, this can be done quickly, yet accurately.

RetCAD™ uses state-of-the-art deep learning and computer vision technology utilizing a large amount of retinal images in order to provide precisely quantified clinical evidence. The software assists eye care specialists in early diagnosis and grading of vision threatening diseases, such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). Simplified visualization of the scan analysis with heat maps help improve patient engagement and prevent severe eyesight problems and blindness.

  • Consistent performance with better patient care

  • Minimized screening and diagnostic lead times

  • Output conform international standards such as ICDR and AREDS

  • Customized integration to user specific workflows

  • Standardized reporting with a simple graphic representation


Medical centers and
eye care specialists

Fast and effective patient triaging

RetCAD™ software can be customized to allow optimal integration in the clinic-specific workflow, in order to reduce workload for certified eye care specialists and to enhance clinical care capacity.
The ability to prioritize faster and objectively which patients need immediate follow-up, opens truly whole new possibilities in eye care. Ophthalmologists can now help more patients quicker by identifying severe symptoms faster.